arrow
D

Damian J. Green

sylvester comprehensive cancer center
H指数:34
被引数:4,459

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Associations of Baseline Cognitive and Psychosocial Function with Clinical Outcomes After Autologous Stem Cell Transplantation in a Multiple Myeloma Sample

基线认知和心理社会功能与多发性骨髓瘤患者自体干细胞移植后临床结局的关联

Cancers
IF4.4
2026-10-120
OA
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response

B细胞系靶向car-t细胞治疗对体液免疫和疫苗诱导的抗体反应的影响

2026-04-070
OAAI
CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation

CSF-1R抑制和lenalidomide协同作用以促进自体干细胞移植后的骨髓瘤控制

Blood
IF23.1
2026-03-040
OAAI
Extracorporeal Photopheresis for Chronic Graft-Versus-Host Disease According to 2014 NIH Consensus Criteria

根据2014年NIH共识标准的外周血光分离置换疗法治疗慢性移植物抗宿主病

2025-11-230
OAAI
Bridging the identity and function of human plasma cells
2025-11-010
PRE
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials

Gamma-分泌酶抑制剂对BCMA CAR-T疗法后多发性骨髓瘤结局的影响:两项I期试验的比较

2025-09-080
PRE
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

双等位基因抗原逃逸是抗CD38抗体在多发性骨髓瘤中的一种耐药机制。

Blood
IF23.1
2025-06-160
PRE
Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population

造血干细胞移植未完成的心理社会相关因素研究:一项针对多样化人群的调查

2025-06-020
PRE
TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies
2024-04-194
OA
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

anti-PD-L1抗体起始时间影响CD19 car-t细胞治疗大b细胞淋巴瘤的疗效/毒性

2024-01-2311
OAAI
Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞治疗后巨细胞病毒 (CMV) 再激活和CMV特异性细胞介导的免疫

2023-11-1718
OAAI
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Anakinra治疗嵌合抗原受体T细胞治疗后难治性细胞因子释放综合征或免疫效应细胞相关神经毒性综合征

2023-07-0160
OAAI
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma

B细胞成熟抗原导向的嵌合抗原受体T细胞治疗多发性骨髓瘤患者的病原体特异性体液免疫和感染

2022-06-0126
OAAI